bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid

C118H103Cl4FN26O10 — CID 158392363

IUPACbis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid
SMILESO=C(/C=C/c1cc(Cl)ccc1-n1cnnn1)N1CCCC(c2ccccc2)C1c1ncc(-c2cccnc2)[nH]1.O=C(/C=C/c1cc(Cl)ccc1-n1cnnn1)N1CCCC(c2ccccc2)C1c1ncc(-c2cccnc2)[nH]1.O=C(O)c1ccc(CC(=O)C2C(c3cccc(F)c3)CCCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.O=C(O)c1ccc(CC(=O)C2C(c3ccccc3)CCCN2C(=O)CCc2cc(Cl)ccc2-n2cnnn2)cc1
InChIInChI=1S/C30H25ClFN5O4.C30H28ClN5O4.2C29H25ClN8O/c31-23-11-12-26(37-18-33-34-35-37)22(16-23)10-13-28(39)36-14-2-5-25(21-3-1-4-24(32)17-21)29(36)27(38)15-19-6-8-20(9-7-19)30(40)41;31-24-13-14-26(36-19-32-33-34-36)23(18-24)12-15-28(38)35-16-4-7-25(21-5-2-1-3-6-21)29(35)27(37)17-20-8-10-22(11-9-20)30(39)40;2*30-23-11-12-26(38-19-33-35-36-38)21(16-23)10-13-27(39)37-15-5-9-24(20-6-2-1-3-7-20)28(37)29-32-18-25(34-29)22-8-4-14-31-17-22/h1,3-4,6-13,16-18,25,29H,2,5,14-15H2,(H,40,41);1-3,5-6,8-11,13-14,18-19,25,29H,4,7,12,15-17H2,(H,39,40);2*1-4,6-8,10-14,16-19,24,28H,5,9,15H2,(H,32,34)/b13-10+;;2*13-10+
InChIKeyGXCSRYKSZBPBFG-JTSOFHECSA-N
MW2206.10 g/mol
LogP19.81
Rot. Bonds29

About bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid

bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid (PubChem CID 158392363) has the molecular formula C118H103Cl4FN26O10 and a molecular weight of 2206.10 g/mol. Its IUPAC name is bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid.

Molecular Properties

Compound Namebis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid
PubChem CID158392363
Molecular FormulaC118H103Cl4FN26O10
Molecular Weight2206.10 g/mol
Exact Mass2202.71
IUPAC Namebis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid
SMILESO=C(/C=C/c1cc(Cl)ccc1-n1cnnn1)N1CCCC(c2ccccc2)C1c1ncc(-c2cccnc2)[nH]1.O=C(/C=C/c1cc(Cl)ccc1-n1cnnn1)N1CCCC(c2ccccc2)C1c1ncc(-c2cccnc2)[nH]1.O=C(O)c1ccc(CC(=O)C2C(c3cccc(F)c3)CCCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.O=C(O)c1ccc(CC(=O)C2C(c3ccccc3)CCCN2C(=O)CCc2cc(Cl)ccc2-n2cnnn2)cc1
InChIInChI=1S/C30H25ClFN5O4.C30H28ClN5O4.2C29H25ClN8O/c31-23-11-12-26(37-18-33-34-35-37)22(16-23)10-13-28(39)36-14-2-5-25(21-3-1-4-24(32)17-21)29(36)27(38)15-19-6-8-20(9-7-19)30(40)41;31-24-13-14-26(36-19-32-33-34-36)23(18-24)12-15-28(38)35-16-4-7-25(21-5-2-1-3-6-21)29(35)27(37)17-20-8-10-22(11-9-20)30(39)40;2*30-23-11-12-26(38-19-33-35-36-38)21(16-23)10-13-27(39)37-15-5-9-24(20-6-2-1-3-7-20)28(37)29-32-18-25(34-29)22-8-4-14-31-17-22/h1,3-4,6-13,16-18,25,29H,2,5,14-15H2,(H,40,41);1-3,5-6,8-11,13-14,18-19,25,29H,4,7,12,15-17H2,(H,39,40);2*1-4,6-8,10-14,16-19,24,28H,5,9,15H2,(H,32,34)/b13-10+;;2*13-10+
InChIKeyGXCSRYKSZBPBFG-JTSOFHECSA-N
XLogP19.81
TPSA447.52 Ų
H-Bond Donors4
H-Bond Acceptors28
Rotatable Bonds29
Heavy Atoms159
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002206.10
LogP ≤ 519.81
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid?
The IUPAC name of bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid (CID 158392363) is bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid.
What is the SMILES notation for bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid?
The canonical SMILES for bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid is O=C(/C=C/c1cc(Cl)ccc1-n1cnnn1)N1CCCC(c2ccccc2)C1c1ncc(-c2cccnc2)[nH]1.O=C(/C=C/c1cc(Cl)ccc1-n1cnnn1)N1CCCC(c2ccccc2)C1c1ncc(-c2cccnc2)[nH]1.O=C(O)c1ccc(CC(=O)C2C(c3cccc(F)c3)CCCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.O=C(O)c1ccc(CC(=O)C2C(c3ccccc3)CCCN2C(=O)CCc2cc(Cl)ccc2-n2cnnn2)cc1.
What is the InChIKey of bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid?
The InChIKey is GXCSRYKSZBPBFG-JTSOFHECSA-N. The full InChI is InChI=1S/C30H25ClFN5O4.C30H28ClN5O4.2C29H25ClN8O/c31-23-11-12-26(37-18-33-34-35-37)22(16-23)10-13-28(39)36-14-2-5-25(21-3-1-4-24(32)17-21)29(36)27(38)15-19-6-8-20(9-7-19)30(40)41;31-24-13-14-26(36-19-32-33-34-36)23(18-24)12-15-28(38)35-16-4-7-25(21-5-2-1-3-6-21)29(35)27(37)17-20-8-10-22(11-9-20)30(39)40;2*30-23-11-12-26(38-19-33-35-36-38)21(16-23)10-13-27(39)37-15-5-9-24(20-6-2-1-3-7-20)28(37)29-32-18-25(34-29)22-8-4-14-31-17-22/h1,3-4,6-13,16-18,25,29H,2,5,14-15H2,(H,40,41);1-3,5-6,8-11,13-14,18-19,25,29H,4,7,12,15-17H2,(H,39,40);2*1-4,6-8,10-14,16-19,24,28H,5,9,15H2,(H,32,34)/b13-10+;;2*13-10+.
What are the key properties of bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid?
bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid has a molecular weight of 2206.10 g/mol, XLogP of 19.81, 29 rotatable bonds, 4 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for bis((E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[3-phenyl-2-(5-pyridin-3-yl-1H-imidazol-2-yl)piperidin-1-yl]prop-2-en-1-one);4-[2-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]propanoyl]-3-phenylpiperidin-2-yl]-2-oxoethyl]benzoic acid;4-[2-[1-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(3-fluorophenyl)piperidin-2-yl]-2-oxoethyl]benzoic acid is sourced from PubChem (CID 158392363), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).